These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3860087)

  • 1. Arginine vasopressin, stress, and memory.
    Koob GF; Lebrun C; Martinez JL; Dantzer R; Le Moal M; Bloom FE
    Ann N Y Acad Sci; 1985; 444():194-202. PubMed ID: 3860087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osmotic stress mimics effects of vasopressin on learned behaviour.
    Koob GF; Dantzer R; Rodriguez F; Bloom FE; Le Moal M
    Nature; 1985 Jun 27-Jul 3; 315(6022):750-2. PubMed ID: 4010780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microinjection of arginine8-vasopressin antiserum into the dorsal hippocampus attenuates passive avoidance behavior in rats.
    Kovács GL; Buijs RM; Bohus B; van Wimersma Greidanus TB
    Physiol Behav; 1982 Jan; 28(1):45-8. PubMed ID: 7079322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin pressor antagonist injected centrally reverses behavioral effects of peripheral injection of vasopressin, but only at doses that reverse increase in blood pressure.
    Lebrun C; Le Moal M; Koob GF; Bloom FE
    Regul Pept; 1985 Jun; 11(2):173-81. PubMed ID: 4035008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of the neurohypophysis in psychological stress].
    Scantamburlo G; Ansseau M; Legros JJ
    Encephale; 2001; 27(3):245-59. PubMed ID: 11488255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of arginine-vasopressin in cerebrospinal fluid during passive avoidance behavior in rats.
    Laczi F; Gaffori O; Fekete M; de Kloet ER; de Wied D
    Life Sci; 1984 Jun; 34(24):2385-91. PubMed ID: 6727572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic neuropeptides and memory.
    van Wimersma Greidanus TB; Jolles J; De Wied D
    Acta Neurochir (Wien); 1985; 75(1-4):99-105. PubMed ID: 3993453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of neonatal administration of vasopressin on cardiac and behavioral responses to emotional stress in adult male rats.
    Buwalda B; Nyakas C; Koolhaas JM; Bohus B
    Physiol Behav; 1991 Nov; 50(5):929-32. PubMed ID: 1805283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can aversive properties of (peripherally-injected) vasopressin account for its putative role in memory?
    Ettenberg A; van der Kooy D; Le Moal M; Koob GF; Bloom FE
    Behav Brain Res; 1983 Mar; 7(3):331-50. PubMed ID: 6838716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of neuropeptides in learning versus performance: focus on vasopressin.
    Koob GF; Lebrun C; Bluthé RM; Dantzer R; Le Moal M
    Brain Res Bull; 1989; 23(4-5):359-64. PubMed ID: 2686806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central injections of arginine vasopressin prolong extinction of active avoidance.
    Koob GF; Dantzer R; Bluthé RM; Lebrun C; Bloom FE; Le Moal M
    Peptides; 1986; 7(2):213-8. PubMed ID: 3737445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of effects of vasopressin (AVP) on inhibitory avoidance by a vasopressin antagonist peptide [dPtyr(Me)AVP].
    LeBrun CJ; Rigter H; Martinez JL; Koob GF; Le Moal M; Bloom FE
    Life Sci; 1984 Oct; 35(14):1505-12. PubMed ID: 6482669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral effects of peripheral administration of arginine vasopressin: a review of our search for a mode of action and a hypothesis.
    Le Moal M; Dantzer R; Mormède P; Baduel A; Lebrun C; Ettenberg A; van der Kooy D; Wenger J; Deyo S; Koob GF
    Psychoneuroendocrinology; 1984; 9(4):319-41. PubMed ID: 6514931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic-midbrain structures.
    Kovács GL; Bohus B; Versteeg DH; de Kloet ER; de Wied D
    Brain Res; 1979 Oct; 175(2):303-14. PubMed ID: 487159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central target for the behavioural effects of vasopressin neuropeptides.
    de Wied D; Gaffori O; van Ree JM; de Jong W
    Nature; 1984 Mar 15-21; 308(5956):276-8. PubMed ID: 6322010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Septal vasopressin modulates motility and passive avoidance in pinealectomized rats.
    Appenrodt E; Schwarzberg H
    Physiol Behav; 1999 Jul; 66(5):757-61. PubMed ID: 10405103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-related memory effects of vasopressin analogues in rats.
    Gaffori OJ; De Wied D
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1125-9. PubMed ID: 3809214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine- and stress-induced secretion of ACTH and beta-endorphin: involvement of corticotropin-releasing hormone and vasopressin.
    Kjaer A; Knigge U; Bach FW; Warberg J
    Neuroendocrinology; 1992 Sep; 56(3):419-28. PubMed ID: 1331840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracerebroventricular application of a vasopressin antagonist peptide prevents the behavioral actions of vasopressin.
    Ettenberg A
    Behav Brain Res; 1984 Dec; 14(3):201-11. PubMed ID: 6549259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitation of passive avoidance response by newly synthesized cationized arginine vasopressin fragment 4-9 in rats.
    Tanabe S; Shishido Y; Furushiro M; Kado K; Hashimoto S; Yokokura T; Ohsawa T
    Pharmacol Biochem Behav; 1997; 57(1-2):251-6. PubMed ID: 9164579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.